The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Design of Peptides with High Affinities for Heparin and Endothelial Cell Proteoglycans
Open accessAbstract
Proteoglycan-binding peptides were designed based on consensus sequences in heparin-binding proteins: XBBXBX and XBBBXXBX, where X and B are hydropathic and basic residues, respectively. Initial peptide constructs included (AKKARA)(n) and (ARKKAAKA)(n) (n = 1-6). Affinity coelectrophoresis revealed that low M(r) peptides (600-1,300) had no affinities for low M(r) heparin, but higher M(r) peptides (2,000-3,500) exhibited significant affinities (K(d) congruent with 50-150 nM), which increased with peptide M(r). Affinity was strongest when sequence arrays were contiguous and alanines and arginines occupied hydropathic and basic positions, but inclusion of prolines was disruptive. A peptide including a single consensus sequence of the serglycin proteoglycan core protein bound heparin strongly (K(d) congruent with 200 nM), likely owing to dimerization through cysteine-cysteine linkages. Circular dichroism showed that high affinity heparin-binding peptides converted from a charged coil to an alpha-helix upon heparin addition, whereas weak heparin-binding peptides did not. Higher M(r) peptides exhibited high affinities for total endothelial cell proteoglycans (K(d) congruent with 300 nM), and approximately 4-fold weaker affinities for their free glycosaminoglycan chains. Thus, peptides including concatamers of heparin-binding consensus sequences may exhibit strong affinities for heparin and proteoglycans. Such peptides may be applicable in promoting cell-substratum adhesion or in the design of drugs targeted to proteoglycan-containing cell surfaces and extracellular matrices.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This notion that multiple binding sites of apoE molecules increase the GAG binding is consistent with the previous study of peptides including heparin binding consensus sequences showing that multiple copies of the heparin binding site enhance the binding affinity through cooperativity effects (51).”
From Role of the N- and C-Terminal Domains in Binding of Apolipoprotein E Isoforms to Heparan Sulfate and Dermatan Sulfate: A Surface Plasmon Resonance Study (2008) · cites this paper as [51]
Citations
Cites
Cell Biology of Extracellular Matrix
Hay, E. D. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0881-2 · Cited by 1,470
Molecular modeling of protein-glycosaminoglycan interactions.
Cardin, A. D., & Weintraub, H. J. R. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.1.21 · Cited by 1,301
Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes
Jackson, R. L., Busch, S. J., & Cardin, A. D. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.2.481 · Cited by 1,099
(1973) · Elsevier eBooks · doi:10.1016/b978-0-12-765601-4.x5001-x · Cited by 1,006
Formation of anhydrosugars in the chemical depolymerization of heparin
Shively, J. E., & Conrad, H. E. (1976) · Biochemistry · doi:10.1021/bi00663a005 · Cited by 905
Maciag, T., Cerundolo, J., Ilsley, S., Kelley, P. R., & Forand, R. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.11.5674 · Cited by 704
Lawler, J., & Hynes, R. O. (1986) · The Journal of Cell Biology · doi:10.1083/jcb.103.5.1635 · Cited by 580
(1998) · Elsevier eBooks · doi:10.1016/b978-0-12-186060-8.x5000-1 · Cited by 504
Cell Biology of Extracellular Matrix
Hay, E. D. (1991) · Springer eBooks · doi:10.1007/978-1-4615-3770-0 · Cited by 388
Murdoch, A. D., Dodge, G. R., COHEN, I. R., Tuan, R. S., & Iozzo, R. V. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42478-7 · Cited by 315
Flagged first, then by citations
Research works printed but not linked: 1
- Iozzo, 1985, Cancer Res., 45, 5677
Cited by
Sorted by citations
Hirst, A. R., Escuder, B., Miravet, J. F., & Smith, D. K. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800022 · Cited by 1,272
Heparin Binding Nanostructures to Promote Growth of Blood Vessels
Rajangam, K. L., Behanna, H. A., Hui, M. J., Han, X., Hulvat, J. F., Lomasney, J. W., & Stupp, S. I. (2006) · Nano Letters · doi:10.1021/nl0613555 · Cited by 417
Therapeutic value of glycosaminoglycans in cancer
Yip, G. W., Smollich, M., & Götte, M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0082 · Cited by 268
Heparin-Binding Domains in Vascular Biology
Munoz, E. M., & Linhardt, R. J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000137189.22999.3f · Cited by 218
Regulation of Schwann cell function by the extracellular matrix
Chernousov, M. A., Yu, W., Chen, Z., Carey, D. J., & Strickland, S. (2008) · Glia · doi:10.1002/glia.20740 · Cited by 201
Heparan sulfate proteoglycans and heparanase—partners in osteolytic tumor growth and metastasis
Sanderson, R. D., Yang, Y., Suva, L. J., & Kelly, T. J. (2004) · Matrix Biology · doi:10.1016/j.matbio.2004.08.004 · Cited by 190
Hirst, A. R., Escuder, B., Miravet, J. F., & Smith, D. K. (2008) · Angewandte Chemie · doi:10.1002/ange.200800022 · Cited by 190
Antimicrobial activities of heparin‐binding peptides
Andersson, E., Rydengård, V., Sonesson, A., Mörgelin, M., Björck, L., & Schmidtchen, A. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04035.x · Cited by 188
Binding sugars: from natural lectins to synthetic receptors and engineered neolectins
Arnaud, J., Audfray, A., & Imberty, A. (2013) · Chemical Society Reviews · doi:10.1039/c2cs35435g · Cited by 170
Johnson, L. N., Cashman, S. M., & Kumar‐Singh, R. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300324 · Cited by 162
Levy‐Adam, F., Abboud-Jarrous, G., Guerrini, M., Beccati, D., Vlodavsky, I., & Ilan, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414546200 · Cited by 146
Billings, P. C., & Pacifici, M. (2015) · Connective Tissue Research · doi:10.3109/03008207.2015.1045066 · Cited by 147
Cell-surface prion protein interacts with glycosaminoglycans
Tao, P. A. N., Wong, B., Tong, L. I. U., Li, R., Petersen, R. B., & Sy, M. (2002) · Biochemical Journal · doi:10.1042/bj20020773 · Cited by 144
Peptide amphiphile nanostructure–heparin interactions and their relationship to bioactivity
Rajangam, K. L., Arnold, M. S., Rocco, M. A., & Stupp, S. I. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.008 · Cited by 123
Hitting multiple targets with multimeric ligands
Handl, H. L., Vágner, J., Han, H., Mash, E. A., Hruby, V. J., & Gillies, R. J. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.6.565 · Cited by 111
Sauer, I., Dunay, I. R., Weisgraber, K. H., Bienert, M., & Dathe, M. (2005) · Biochemistry · doi:10.1021/bi048080x · Cited by 117
Effect of Peptide Length on the Interaction between Consensus Peptides and DOPC/DOPA Bilayers
Ringstad, L., Schmidtchen, A., & Malmsten, M. (2006) · Langmuir · doi:10.1021/la060317y · Cited by 104
Levy‐Adam, F., Feld, S., Suss-Toby, E., Vlodavsky, I., & Ilan, N. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002319 · Cited by 98
Physical Polymer Matrices Based on Affinity Interactions between Peptides and Polysaccharides
Seal, B. L., & Panitch, A. (2003) · Biomacromolecules · doi:10.1021/bm0342032 · Cited by 93
Characterization of the Heparin Binding Sites in Human Apolipoprotein E
Saito, H., Dhanasekaran, P., Nguyen, D., Baldwin, F., Weisgraber, K. H., Wehrli, S., Phillips, M. C., & Lund-Katz, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213207200 · Cited by 90
Polycationic calix[8]arenes able to recognize and neutralize heparin
Mecca, T., Consoli, G. M. L., Geraci, C., Spina, R. L., & Cunsolo, F. (2006) · Organic & Biomolecular Chemistry · doi:10.1039/b608887b · Cited by 88
Bonito, V., Smits, A. I. P. M., Goor, O. J. G. M., Ippel, B. D., Driessen‐Mol, A., Münker, T. J. A. G., Bosman, A. W., Mes, T., Dankers, P. Y. W., & Bouten, C. V. C. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.02.032 · Cited by 80
Sagnella, S. M., Anderson, E., Sanabria, N., Marchant, R. E., & Kottke‐Marchant, K. (2005) · Tissue Engineering · doi:10.1089/ten.2005.11.226 · Cited by 69
Minimal Peptide Motif for Non-covalent Peptide–Heparin Hydrogels
Wieduwild, R., Tsurkan, M. V., Chwalek, K., Murawala, P., Nowak, M., Freudenberg, U., Neinhuis, C., Werner, C., & Zhang, Y. (2013) · Journal of the American Chemical Society · doi:10.1021/ja312022u · Cited by 69
Fusion to a highly stable consensus albumin binding domain allows for tunable pharmacokinetics
Jacobs, S. A., Gibbs, A. C., Conk, M., Yi, F., Maguire, D., Kane, C. M., & O’Neil, K. T. (2015) · Protein Engineering Design and Selection · doi:10.1093/protein/gzv040 · Cited by 65
Zhu, M., Zhong, W., Cao, W., Zhang, Q., & Wu, G. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.07.004 · Cited by 63
Depot-Based Delivery Systems for Pro-Angiogenic Peptides: A Review
Hove, A. H. V., & Benoit, D. S. W. (2015) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2015.00102 · Cited by 62
Yamauchi, Y., Deguchi, N., Takagi, C., Tanaka, M., Dhanasekaran, P., Nakano, M., Handa, T., Phillips, M. C., Lund-Katz, S., & Saito, H. (2008) · Biochemistry · doi:10.1021/bi8003999 · Cited by 53
Binding and Release of Consensus Peptides by Poly(acrylic acid) Microgels
Bysell, H., Schmidtchen, A., & Malmsten, M. (2009) · Biomacromolecules · doi:10.1021/bm9003354 · Cited by 55
Schwann Cells Synthesize Type V Collagen That Contains a Novel α4 Chain
Chernousov, M. A., Rothblum, K. N., Tyler, W. A., Stahl, R. C., & Carey, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003922200 · Cited by 55
Naik, R. J., Chandra, P., Mann, A., & Ganguli, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.227793 · Cited by 50
Strategies to improve the hemocompatibility of biodegradable biomaterials
Mulinti, P., Brooks, J. E., Lervick, B., Pullan, J. E., & Brooks, A. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100497-5.00017-3 · Cited by 49
Datta, G., Garber, D. W., Chung, B. H., Chaddha, M., Dashti, N., Bradley, W. A., Gianturco, S. H., & Anantharamaiah, G. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31620-5 · Cited by 49
Wu, C., & Wang, S. (2011) · Journal of Virology · doi:10.1128/jvi.06357-11 · Cited by 46
Enhancement of cell attachment and tissue integration by a IKVAV containing multi-domain peptide
Lin, X., Takahashi, K., Liu, Y., & Zamora, P. O. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.05.010 · Cited by 47
Wang, N., Zhai, X., Li, X., Wang, Y., He, W., Jiang, Z., Veit, M., & Su, S. (2022) · Journal of Virology · doi:10.1128/jvi.01751-21 · Cited by 46
Multidomain Synthetic Peptide B2A2 Synergistically Enhances BMP-2 In Vitro
Lin, X., Zamora, P. O., Albright, S., Glass, J. D., & Peña, L. A. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041104 · Cited by 45
GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models
Torphy, R. J., Sun, Y., Lin, R., Caffrey-Carr, A. K., Fujiwara, Y., Ho, F., Miller, E. N., McCarter, M. D., Lyons, T. R., Schulick, R. D., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27658-x · Cited by 44
Synthetic peptide F2A4-K-NS mimics fibroblast growth factor-2 in vitro and is angiogenic in vivo
Lin, X., Takahashi, K., Campion, S., Liu, Y., Gustavsen, G. G., Peña, L. A., & Zamora, P. O. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.5.833 · Cited by 44
Schick, B. P., Maslow, D. E., Moshinski, A., & Antonio, J. D. S. (2003) · Blood · doi:10.1182/blood-2003-07-2334 · Cited by 41
Self-citationInhibition of antithrombin by Plasmodium falciparum histidine-rich protein II.
Ndonwi, M., Burlingame, O., Miller, A. S., Tollefsen, D., Broze, G., & Goldberg, D. (2011) · Blood · doi:10.1182/blood-2010-12-326876 · Cited by 44
Erdman, R., Stahl, R. C., Rothblum, K. N., Chernousov, M. A., & Carey, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111311200 · Cited by 40
Quantitative analyses reveal extracellular dynamics of Wnt ligands in Xenopus embryos
Mii, Y., Nakazato, K., Pack, C., Ikeda, T., Sako, Y., Mochizuki, A., Taira, M., & Takada, S. (2021) · eLife · doi:10.7554/elife.55108 · Cited by 37
Sakharov, D. V., Jie, A. F. H., Bekkers, M., EMEIS, J. J., & Rijken, D. C. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.6.943 · Cited by 38
Hakansson-McReynolds, S., & Caffrey, M. S. (2003) · Biochemistry · doi:10.1021/bi020715+ · Cited by 36
Moise, A., André, S., Eggers, F., Krzeminski, M., Przybylski, M., & Gabius, H. (2011) · Journal of the American Chemical Society · doi:10.1021/ja201967v · Cited by 35
Increased Expression of Serglycin in Specific Carcinomas and Aggressive Cancer Cell Lines
Korpetinou, A., Papachristou, D. J., Lampropoulou, A., Bouris, P., Labropoulou, V., Noulas, A., Karamanos, N. K., & Theocharis, A. D. (2015) · BioMed Research International · doi:10.1155/2015/690721 · Cited by 35
Siebert, H., Born, K., André, S., Frank, M., Kaltner, H., von der Lieth, C., Heck, A. J. R., Jiménez‐Barbero, J., Kopitz, J., & Gabius, H. (2005) · Chemistry - A European Journal · doi:10.1002/chem.200500505 · Cited by 34
Naik, R. J., Chatterjee, A., & Ganguli, M. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.02.010 · Cited by 30
Divergent Heparin‐Induced Fibrillation Pathways of a Prion Amyloidogenic Determinant
Bazar, E., & Jelinek, R. (2010) · ChemBioChem · doi:10.1002/cbic.201000207 · Cited by 30
Emerging and potential therapies for Alzheimer's disease
Jarosz-Griffiths, H., Morten, I. J., & Hooper, N. M. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.6.693 · Cited by 30
Speth, M., Seibold, K., & Katz, N. R. (2002) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00328-4 · Cited by 27
Serglycin Proteoglycan Deletion in Mouse Platelets
Schick, B. P. (2010) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(10)93011-1 · Cited by 25
Self-citationMurugesan, G., Ruegsegger, M. A., Kligman, F. L., Marchant, R. E., & Kottke‐Marchant, K. (2002) · Cell Communication & Adhesion · doi:10.1080/15419060214148 · Cited by 24
Serglycin Proteoglycan Synthesis in the Murine Uterine Decidua and Early Embryo1
Ho, H.-C. K., McGrath, K. E., Brodbeck, K. C., Palis, J., & Schick, B. P. (2001) · Biology of Reproduction · doi:10.1095/biolreprod64.6.1667 · Cited by 23
Self-citationBinding of a de novo designed peptide to specific glycosaminoglycans
Jayaraman, G., Wu, C., Liu, Y. J., Chien, K., Fang, J., & Lyu, P. C. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01964-5 · Cited by 22
Gradowski, J., Antonio, J. S., Martinez, J., & Schick, B. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615609 · Cited by 22
Self-citationTrybala, E., Olofsson, S., Mårdberg, K., Svennerholm, B., Umemoto, K., Glorioso, J. C., & Bergström, T. B. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2003.12.007 · Cited by 21
Detection and neutralisation of heparin by a fluorescent ruthenium compound
Szelke, H., Harenberg, J., & Krämer, R. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-03-0168 · Cited by 20
Pimenta, D. C., Nantes, I. L., de Souza, E. S., Bonniec, B. L., Ito, A. S., Tersariol, I. L. S., Oliveira, V., Juliano, M. A., & Juliano, L. (2002) · Biochemical Journal · doi:10.1042/bj20020023 · Cited by 20
Mao, D., Liu, J., Ji, S., Wang, T., Hu, Y., Zheng, D., Yang, R., Kong, D., & Ding, D. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.038 · Cited by 19
Chemically modified poly(2‐hydroxyethyl methacrylate) cryogel for the adsorption of heparin
Spina, R. L., Tripisciano, C., Mecca, T., Cunsolo, F., Weber, V., & Mattìasson, B. (2014) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.33104 · Cited by 17
Sen, S., Sharma, P., Pal, V. K., & Roy, S. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.3c00621 · Cited by 16
Targeting Biological Polyanions in Blood: Strategies toward the Design of Therapeutics
La, C. C., Takeuchi, L. E., Abbina, S., Vappala, S., Abbasi, U., & Kizhakkedathu, J. N. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00654 · Cited by 16
Doss-Pepe, E., Deprez, P. N., Inestrosa, N. C., & Brodsky, B. (2000) · Biochemistry · doi:10.1021/bi001108u · Cited by 16
Crijns, H., Adyns, L., Ganseman, E., Cambier, S., Vandekerckhove, E., Pörtner, N., Vanbrabant, L., Struyf, S., Gerlza, T., Kungl, A. J., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010447 · Cited by 15
Effects of a Bioactive SPPEPS Peptide on Chondrogenic Differentiation of Mesenchymal Stem Cells
Mahzoon, S., Townsend, J. M., Lam, T. N., Sjoelund, V. H., & Detamore, M. S. (2019) · Annals of Biomedical Engineering · doi:10.1007/s10439-019-02306-0 · Cited by 15
Castronuevo, P., Thornton, M. A., McCarthy, L. E., Klimas, J., & Schick, B. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310220200 · Cited by 14
Self-citationPeptide Regulation of Chondrogenic Stem Cell Differentiation
Linkova, N. S., Khavinson, V., Diatlova, A., Myakisheva, S. N., & Ryzhak, G. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098415 · Cited by 13
Mulinti, P., Kalita, D., Hasan, M. S., Quadir, M., Wang, Y., & Brooks, A. E. (2020) · Materialia · doi:10.1016/j.mtla.2020.100937 · Cited by 13
Chondroinductive Peptides: Drawing Inspirations from Cell–Matrix Interactions
Mahzoon, S., & Detamore, M. S. (2018) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2018.0003 · Cited by 11
Stepwise construction of triple-helical heparin binding sites using peptide models
Doss-Pepe, E., Deprez, P. N., Silva, T., Inestrosa, N. C., Kirkpatrick, A., Ramshaw, J. A. M., & Brodsky, B. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.034 · Cited by 11
Binding and retention of polycationic peptides and dendrimers in the vascular wall
Sakharov, D. V., Jie, A. F. H., Filippov, D. V., Bekkers, M., BOOM, J. H. V., & Rijken, D. C. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00063-2 · Cited by 11
La, C. C., Smith, S. A., Kalathottukaren, M. T., Haynes, C. A., Morrissey, J. H., & Kizhakkedathu, J. N. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400108 · Cited by 10
Heparin Dependent Coiled‐Coil Formation
Nitz, M., Rullo, A. F., & Ding, M. X. Y. (2008) · ChemBioChem · doi:10.1002/cbic.200800056 · Cited by 10
Hoke, D. E., Carson, D. D., & Höök, M. (2003) · Journal of Negative Results in BioMedicine · doi:10.1186/1477-5751-2-1 · Cited by 10
Polycationic peptides as inhibitors of mast cell serine proteases
Lundequist, A., Juliano, M. A., Juliano, L., & Pejler, G. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00044-3 · Cited by 10
Mulinti, P., Diekjürgen, D., Kurtzeborn, K., Balasubramanian, N., Stafslien, S. J., Grainger, D. W., & Brooks, A. E. (2022) · Bioengineering · doi:10.3390/bioengineering9020046 · Cited by 9
Heparin‐guided binding of vascular endothelial growth factor to supramolecular biomaterial surfaces
Schmitz, M. G. J., Ibrahim, D. M., Bartels, P. A. A., Twisk, S. A. E., Smits, A. I. P. M., Bouten, C. V. C., & Dankers, P. Y. W. (2023) · Journal of Polymer Science · doi:10.1002/pol.20230056 · Cited by 8
Design, Synthesis, and Characterization of Heparin-Binding Peptoids
Ford, B. K., Hamza, M., & Rabenstein, D. L. (2013) · Biochemistry · doi:10.1021/bi4001722 · Cited by 8
Heparin reversal through an entire encapsulation strategy by giant macrocycles
Xiang, Y., Zhang, Y., Tian, L., Zhang, F., Zhang, Z., Chen, L., Chen, J., Li, C., & Meng, Q. (2024) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2024.102044 · Cited by 8
A Peptide Found by Phage Display Discriminates a Specific Structure of a Trisaccharide in Heparin
Yabe, T., Hosoda‐Yabe, R., Kanamaru, Y., & Kiso, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.172155 · Cited by 8
Yang, E., Mundy, C., Rappaport, E. F., Pacifici, M., & Billings, P. C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222784 · Cited by 6
Microarrays for the screening and identification of carbohydrate-binding peptides
Shastry, D. G., & Karande, P. (2019) · The Analyst · doi:10.1039/c9an01465a · Cited by 6
HEMA-Lysine-Based Cryogels for Highly Selective Heparin Neutralization
Mecca, T., Spitaleri, F., Spina, R. L., Gioria, S., Giglio, V., & Cunsolo, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126503 · Cited by 5
Affinity Coelectrophoresis of Proteoglycan-Protein Complexes
Antonio, J. D. S., & Lander, A. D. (2003) · Humana Press eBooks · doi:10.1385/1-59259-209-0:401 · Cited by 5
Fibroblast Growth Factor-Derived Peptides: Sources, Functions, and Applications
Cao, C.-K., Shi, Z.-Y., Chen, C.-B., Li, X., & Su, Z. (2025) · Bioengineering · doi:10.3390/bioengineering12101019 · Cited by 4
Understanding and manipulating extracellular behaviors of Wnt ligands
Mii, Y. (2024) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-024-00856-9 · Cited by 4
Fret Studies of Conformational Changes in Heparin-Binding Peptides
de Souza, E. S., Katagiri, A. H., Juliano, L., Juliano, M. A., Pimenta, D. C., & Ito, A. S. (2014) · Journal of Fluorescence · doi:10.1007/s10895-014-1366-3 · Cited by 4
Analysis of xylosyltransferase II binding to the anticoagulant heparin
Casanova, J. C., Ambrosius, M., Kühn, J., Kleesiek, K., & Götting, C. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.050 · Cited by 4
Peptides in the clinic today: The leading families and their applications
Azadvari, N., Gomersall, W., Burress, B., & Hosseinzadeh, P. (2025) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2025.09.012 · Cited by 2
A clamp‐like orientation of basic residues set in a parallelogram is essential for heparin binding
Cheng, Y., Cheng, C., Lee, T., Chang, W. W., & Lyu, P. C. (2016) · FEBS Letters · doi:10.1002/1873-3468.12361 · Cited by 3
Mantsou, A., Papachristou, E., Κeramidas, P., Lamprou, P., Pitou, M., Papi, R. M., Dimitriou, K., Aggeli, A., & Choli‐Papadopoulou, T. (2023) · Biomedicines · doi:10.3390/biomedicines11071890 · Cited by 3
Wu, C. W., Jayaraman, G., Chien, K. Y., Liu, Y. J., & Lyu, P. (2003) · Peptides · doi:10.1016/j.peptides.2003.10.004 · Cited by 3
Synthesis of peptide homo‐ and heterodimers as potential mimics of platelet‐derived growth factor BB
Stubbing, L. A., Kaur, H., Feng, S. X., Aalderink, M., Dragunow, M., & Brimble, M. A. (2020) · Peptide Science · doi:10.1002/pep2.24150 · Cited by 2
Energy Transfer Systems for In Vivo Tracking
Neri, R., Yapa, A. S., & Bossmann, S. H. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0364-2_5 · Cited by 1
Mantsou, A., Papachristou, E., Κeramidas, P., Lamprou, P., Pavlidis, A., Papi, R. M., Dimitriou, K., Aggeli, A., & Choli‐Papadopoulou, T. (2023) · Nanomaterials · doi:10.3390/nano13071236 · Cited by 1
Peptide-functionalized hydrogels for three-dimensional cell culture
Scott, C. M. (2016) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 1
New insights in platelet signaling by Low Density Lipoprotein
Relou, I. A. M. (2003) · Utrecht University Repository (Utrecht University)
Untersuchungen zur biochemischen Charakterisierung der humanen Xylosyltransferase I und II
Müller, S. (2005) · PUB – Publications at Bielefeld University (Bielefeld University)
Metadata
- Authors
- Verrecchio, A., Germann, M. W., Schick, B. P., Kung, B., Twardowski, T., & San Antonio, J. D.
- Affiliations
- Thomas Jefferson University (US)
- Drexel University (US)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-03
- Volume
- 275
- Issue
- 11
- Pages
- 7701-7707
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2146240095
- Cited by
- 102
- References
- 42
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 2 · 2013: 5
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl029282-15)
- National Heart, Lung, and Blood Institute (HL29282, HL 53590)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Physical Sciences › Materials Science › Surfaces, Coatings and Films › Polymer Surface Interaction Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- heparin-binding peptides, peptide binding affinity, peptide dimerization, alpha-helix formation, glycosaminoglycan chains, cell-substrate adhesion
- MeSH terms
- Amino Acid Sequence, Circular Dichroism, Endothelium, Vascular, Heparin, Humans, Molecular Sequence Data, Oligopeptides, Peptides, Protein Binding, Proteoglycans, Consensus Sequence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review